Extractus Ltd reposted this
We would like to announce Mr. Rick Reiley from Extractus Ltd as our Official Speaking Partner at our upcoming "𝟐𝐧𝐝 𝐀𝐧𝐧𝐮𝐚𝐥 𝐌𝐞𝐝𝐢𝐜𝐚𝐥 𝐃𝐞𝐯𝐢𝐜𝐞 𝐁𝐢𝐨𝐜𝐨𝐦𝐩𝐚𝐭𝐢𝐛𝐢𝐥𝐢𝐭𝐲 𝐂𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞" that will take place as planned on the 𝟐𝟎𝐭𝐡 – 𝟐𝟏𝐬𝐭 𝐍𝐨𝐯𝐞𝐦𝐛𝐞𝐫 𝟐𝟎𝟐𝟒 in Berlin Germany Conference venue our partner hotel: 𝐍𝐨𝐯𝐨𝐭𝐞𝐥 𝐁𝐞𝐫𝐥𝐢𝐧 𝐌𝐢𝐭𝐭𝐞 𝐇𝐨𝐭𝐞𝐥, address: Fischerinsel 12, 10179, Berlin Germany. ISO 10993-18 "Chemical Characterization of Medical Device Materials within a Risk Management Process" is a complex document that encompasses the wide variety of devices but it is not always clear what needs to be performed, the required sensitivity of analytical methods, which compounds must be identified and assessed for toxicological risk in order to comply with the MDR. This presentation details how to determine what testing should be performed along with examples for various applications in order to be successful with EU applications. Mr. Rick Reiley is a Chief Scientific Officer in Extractus Ltd and Global expertise in E&L, led GSK and Haleon's E&L teams for pharma and consumer health. Previously Director of Drug Development for a pharmaceutical startup with 20+ years in R&D. Extractus was formed from the ashes of an ophthalmology startup; we saw a need for a CRO that could offer expert services at reasonable prices. Our team knows the E&L space, pharma and medical devices as well as how to get drugs/devices approved, and our team understands the customer's perspective, priorities, and challenges. Our state-of-the-art laboratory in Oxfordshire is built around efficiency, high resolution mass spectrometry, identification, and quantification of unknowns. To get more information regarding potential participation please follow the link: https://lnkd.in/ddN4qazS #annual #medical #device #biocompatibility #conference #medicaldevices #medicaldevice #toxicology #MDR #medicaldevicemanufacturing #regulatoryaffairs #medicalresearch #medicaldeviceregulations #medicaldeviceindustry #medicaldesign #medicaldeviceindustry